Comparative pharmacology of ofatumumab versus ocrelizumab in humanised-CD20 transgenic mice. P298. In: 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 26–28 October, 2022 - Bigaud, M (2022)